Angelika Fath-Goodin serves as the Chief Scientific Officer and CEO at ParaTechs Corporation since 2004 and co-founded Lepidext LLC in 2015, where Angelika continues to be a member. Previous experience includes a tenure as Scientist II in the Department of Entomology at the University of Kentucky from 2002 to 2008. Angelika Fath-Goodin earned a postdoctoral degree in Plant Physiology from the University of California, Berkeley, from 1995 to 2002, and completed a degree in Plant Biochemistry at the Friedrich Miescher Institute, Biocenter University of Basel, Switzerland, from 1992 to 1995.